Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition
Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence Highlights Binding term sheet signed to acquire key assets and IP of AusCann Group Holdings Ltd. Assets include Neuvis® drug delivery platform, FDA-facing epilepsy pre-clinical data, EU-GMP manufacturing, and German pharma distribution. Strengthens Argent’s clinical pipeline, IP portfolio, and European infrastructure. Adds audited assets […]
GoldMining Files Early Warning Report
VANCOUVER, BC, Aug. 27, 2025 /PRNewswire/ – GoldMining Inc. (the “Company”) has disposed of 3,500,000 common shares (“Shares”) of NevGold Corp. (“NevGold”) pursuant to a block trade over the facilities of the TSX Venture Exchange. Prior to the disposition, the Company beneficially owned and exercised control and direction over 22,573,350 NevGold Shares, representing approximately 19.8% of […]
Joint Statement from NAMI National and NAMI Minnesota on Tragic Shooting at Annunciation Church and School
MINNEAPOLIS, Aug. 27, 2025 /PRNewswire/ — NAMI National and NAMI Minnesota, the national and state offices of the National Alliance on Mental Illness, are deeply saddened by the devastating shooting and loss of life at Annunciation Church and School in Minneapolis. With each school shooting, there is a lasting and far-reaching impact on the mental […]
Androgen Receptor Targeted Therapies Market Forecast: Key Trends and Growth Projections Across the 7MM During the Forecast Period (2025-2034) | DelveInsight
The market for androgen receptor–targeted therapies is projected to expand substantially in the years ahead. This growth is being driven by rising cancer incidence, greater awareness of these therapies, and an increasing pipeline of androgen receptor–targeted treatments currently in clinical trials and awaiting regulatory approval from multiple companies. LAS VEGAS, Aug. 27, 2025 /PRNewswire/ — […]
Banco Macro Announces Results for the Second Quarter of 2025
BUENOS AIRES, Argentina, Aug. 27, 2025 /PRNewswire/ — Banco Macro S.A. (NYSE: BMA; BYMA: BMA) (“Banco Macro” or “BMA” or the “Bank”) announced today its results for the second quarter ended June 30, 2025 (“2Q25”). All figures are in Argentine pesos (Ps.) and have been restated in terms of the measuring unit current at the […]
Artera Celebrates Industry Recognitions and Leadership Promotions
Artera Earns Frost & Sullivan’s 2025 Technology Innovation Leader Recognition and Inc. 5000 America’s Fastest-Growing Private Companies SANTA BARBARA, Calif., Aug. 27, 2025 /PRNewswire/ — Artera, a SaaS leader transforming patient experience with AI-powered virtual agents (voice and text), has been recognized by Frost & Sullivan as the 2025 North American Technology Innovation Leader and […]
Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight
The diffuse large B-cell lymphoma (DLBCL) market size was USD 4.7 billion in the leading markets (the US, EU4, UK, and Japan) in 2024. The DLBCL market is expected to cross USD 11.5 billion by 2034 in the United States. Factors such as an increase, along with the usage and expansion of approved CAR-Ts and […]
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm
NEW YORK, Aug. 27, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline in the securities class action first filed […]
FI Investors Have Opportunity to Lead Fiserv, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 27, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline. So What: If you purchased Fiserv […]
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 27, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, […]